<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02717247</url>
  </required_header>
  <id_info>
    <org_study_id>2015-A00028-41</org_study_id>
    <nct_id>NCT02717247</nct_id>
  </id_info>
  <brief_title>Transcranial Random Noise Stimulation in Food Addiction Treatment</brief_title>
  <acronym>tRNS-FA</acronym>
  <official_title>Effect of Transcranial Random Noise Stimulation of Prefrontal Cortex on Craving Supply Subject Suffering From Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hôpital le Vinatier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hôpital le Vinatier</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obesity is worldwide a public health problem. According to World Health Organization (WHO),
      overweight and obesity are the fifth death risk factor worldwide. At least 2.8 million adults
      die each year. Food addiction is one of the causes of obesity that may benefit from new
      therapeutic options.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Transcranial random noise stimulation is a noninvasive brain stimulation technic. The
      modulation of the electrical activity of the right and left dorsolateral prefrontal cortex
      (DLPFC) by tRNS is able to act on the phenomenon of craving in other addictions. This allows
      us to make the assumption that tRNS stimulation could constitute a treatment for food
      addiction especially in obesity.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 2016</start_date>
  <completion_date type="Anticipated">September 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effects on craving frequencies</measure>
    <time_frame>Change from baseline after 3 months</time_frame>
    <description>by questionnaires scores and declarative number of food</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in body weight</measure>
    <time_frame>Change from baseline after 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in waist circumference</measure>
    <time_frame>Change from baseline after 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in body mass index</measure>
    <time_frame>Change from baseline after 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in biological markers such as lipid profile, ghrelin, leptin, prolactin</measure>
    <time_frame>Change from baseline after 3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Overweight, Obesity and Other Hyperalimentation (E65-E68)</condition>
  <arm_group>
    <arm_group_label>Active tRNS treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention consists in active tRNS stimulation with cathode above the left dorsolateral prefrontal cortex (DLPFC) which corresponds to the F3 location given by the 10-20 system. Anode is above the right dorsalateral prefrontal cortex (F4).
100 (Hertz)Hz-650Hz, 2milliampere(mA), 30min, twice daily, 5 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo tRNS treatment</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The intervention consists in placebo or sham tRNS stimulation electrode are above F3 and F4. Voltage will be ramped at the begin and end of a stimulation for 30 seconds. Placebo stimulation will consist of just applying the ramps at the begin and end of the stimulation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active tRNS</intervention_name>
    <description>The intervention consists in active tRNS stimulation with cathode above the left dorsolateral prefrontal cortex (DLPFC) which corresponds to the F3 location given by the 10-20 system. Anode is above the right dorsolateral prefrontal cortex (F4).
100Hz-650Hz, 2mA, 30min, twice daily, 5 days</description>
    <arm_group_label>Active tRNS treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham tRNS</intervention_name>
    <description>The intervention consists in placebo or sham tRNS stimulation electrode are above F3 and F4. Voltage will be ramped at the begin and end of a stimulation for 30 seconds. Placebo stimulation will consist of just applying the ramps at the begin and end of the stimulation.</description>
    <arm_group_label>Placebo tRNS treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female or male between 18 and 65 years old

          -  Patients suffering from obesity, with a BMI ≥ 30.

          -  Food dependence score at the Yale Food addiction Scale ≥ 3

        Exclusion Criteria:

          -  Presence of a an other psychiatric diagnosis of Axis I (DSM IV);

          -  Presence of addictive comorbidity other than food addiction

          -  Psychotropic treatment;

          -  Pregnancy or lactation;

          -  Contraindication to fMRI .
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>D'AMATO THIERRY, PUPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH LE VINATIER</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>D'AMATO THIERRY, PUPH</last_name>
    <phone>003337915100</phone>
    <email>thierry.damato@ch-le-vinatier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ICETA SYLVAIN, PH</last_name>
    <phone>0033427857769</phone>
    <email>sylvain.iceta@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Le Vinatier</name>
      <address>
        <city>Bron Cedex</city>
        <zip>69678</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry D'AMATO, PH</last_name>
      <phone>04 37 91 51 00</phone>
      <email>thierry.damato@ch-le-vinatier.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2016</study_first_submitted>
  <study_first_submitted_qc>March 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 23, 2016</study_first_posted>
  <last_update_submitted>February 7, 2018</last_update_submitted>
  <last_update_submitted_qc>February 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tRNS</keyword>
  <keyword>Food addiction,</keyword>
  <keyword>Obesity</keyword>
  <keyword>Craving</keyword>
  <keyword>functional magnetic resonance imaging (fMRI)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Hyperphagia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

